Top compounds associated with response to RABGGTA


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.066 0.07
mRNA Pyrimethamine GDSC1000 pan-cancer AAC -0.1 0.07
mRNA A-770041 GDSC1000 pan-cancer AAC -0.1 0.07
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.071 0.07
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.071 0.07
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.068 0.07
mRNA TW 37 GDSC1000 pan-cancer AAC -0.062 0.07
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.096 0.07
mRNA TAK-715 GDSC1000 pan-cancer AAC 0.061 0.08
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.08
Download CSV